← Every company
Supernus Pharmaceuticals Inc SEC Filings
What Supernus Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
SUPN overview →Filings on file
188
since Nov 10, 2016
Warning signs
12
latest Mar 2, 2023
Last results
Aug 3, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 3, 2026 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Feb 24, 2026 | Executive or director change 8-K | Read ↗ |
| Aug 4, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 24, 2025 | Executive or director change 8-K | Read ↗ |
| Apr 24, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 28, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 21, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 1, 2023 | Executive or director change 8-K | Read ↗ |
| Feb 28, 2022 | Executive or director changeResults announced 8-K | Read ↗ |
| Jul 29, 2021 | Executive or director change 8-K | Read ↗ |
| Feb 24, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 19, 2020 | Executive or director change 8-K | Read ↗ |
| Oct 5, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 27, 2020 | Executive or director changeResults announcedMaterial agreement 8-K | Read ↗ |
| Feb 26, 2019 | Executive or director changeResults announced 8-K | Read ↗ |
| Jul 2, 2018 | Executive or director change 8-K | Read ↗ |
| May 17, 2018 | Executive or director change 8-K | Read ↗ |
| May 11, 2018 | Executive or director change 8-K | Read ↗ |
| Feb 20, 2018 | Executive or director change 8-K | Read ↗ |
| Jan 16, 2018 | Delisting notice or listing transferExecutive or director change 8-K | Read ↗ |
| Mar 1, 2017 | Executive or director changeResults announced 8-K | Read ↗ |
Source: Supernus Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on SUPN
Company overviewEverything on SUPN in one place, with the price.Insider tradingWhat SUPN's own officers and directors buy and sell.Executive payWhat SUPN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in SUPN.Funds holding itWhich funds and ETFs hold SUPN, and how big a bet.LobbyingWhat SUPN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on SUPN's account, and who they worked for.PatentsWhat SUPN is filing at the patent office.